Submucosal Fibrosis Prediction in Colorectal Tumor undergoing ESD

Submucosal Fibrosis Prediction in Colorectal Tumor undergoing ESD - Fibrosis in colorectal ESD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029470

Enrollment

500

Registered

2017-11-30

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing colorectal ESD following the indication proposed by JGES

Exclusion criteria

Exclusion criteria: 1. Patients who have recurrent colorectal tumor on prior EMR or ESD site 2. Patients with tumors associated with chronic intestinal inflammation conditions, including ulcerative colitis 3. Patients with hyperplastic polyps, inflammatory polyps and neuroendocrine tumors

Design outcomes

Primary

Measure	Time frame
Predictive factors for presence of severe submucosal fibrosis(F2) in colorectal tumor undergoing ESD	—

Secondary

Measure	Time frame
Clinical outcome of ESD in patients with severe fibrosis	—

Countries

Japan

Contacts

Public ContactUayporn Kaosombatwattana

Nagoya University Graduate School of Medicine Gastroenterology

koigi214@gmail.com0527442172

Outcome results